您当前的位置:国际号刊-季刊 > AMI入库 > 经管 >
南开管理评论国际期刊(英文)(Nankai Business Review International)(国际刊号)

南开管理评论国际期刊(英文)(Nankai Business Review International)(国际刊号)

  • AMI入库
基本信息
  • 主管单位:

  • 主办单位:

    南开大学商学院

  • 国际刊号:

    2040-8749

  • 国内刊号:

  • 学科分类:

    经管

  • 字数:

    -

  • 有无基金:

     

  • 周期:

    国际号刊-季刊

  • 特殊属性:

    外文期刊

联系信息
  • 电话:

  • 邮箱:

    nbri@mail.nankai.edu.cn(公众号信息)

  • 复合因子:

    0

  • 综合因子:

    0

  • 收录:

  • 级别:

    AMI入库

期刊简介

《南开管理评论国际期刊(英文)(Nankai Business Review International)(国际刊号)》期刊已被查看:

更新频次

单位占比

一作占比

投稿指南

1、该刊只有国际刊号。

2、投稿方式:在线投稿。

3、官网网址:

https://www.emeraldgrouppublishing.com/journal/nbri

4、投稿系统:https://mc.manuscriptcentral.com/nbri

5、相关网址:http://nbr.nankai.edu.cn

(《南开管理评论》官网,从此网页可进入Nankai Business Review International官网)

6、邮箱:nbri@mail.nankai.edu.cn(微信公众号信息)

官网期刊编辑邮箱如下。

7、出刊日期:季刊,一年出版4期。

8、微信公众号:南开管理评论

2021年9月28日星期二

《南开管理评论国际期刊(英文)》

(Nankai Business Review International)期刊简介

【微信公众号“南开管理评论”信息】

南开管理评论 2021-09-21

《南开管理评论国际期刊(Nankai Business Review International)》由南开大学商学院与英国爱墨瑞得出版集团(Emerald)共同出版,于2010年2月创刊,是国内第一本管理学国际期刊。该刊特聘国内外知名工商管理、管理科学与工程、金融等相关领域的知名学者,担任期刊副主编和编委会成员,重点发表具有中国情景的管理学领域最新高水平研究成果与综述文章。本刊已被ESCI、Scopus等数据库收录,目前为Emerald出版社在中国地区重点支持的SSCI来源申请期刊。欢迎关注与投稿。

联系我们:

邮箱:nbri@mail.nankai.edu.cn

主页:http://nbr.nankai.edu.cn(English)

投稿网址:https://mc.manuscriptcentral.com/nbri

《南开管理评论国际期刊(英文)》

(Nankai Business Review International)作者指南

【官网信息】

Author guidelines

Before you start

For queries relating to the status of your paper pre decision, please contact the Editor or Journal Editorial Office. For queries post acceptance, please contact the Supplier Project Manager. These details can be found in the Editorial Team section.

Author responsibilities

Our goal is to provide you with a professional and courteous experience at each stage of the review and publication process. There are also some responsibilities that sit with you as the author. Our expectation is that you will:

Respond swiftly to any queries during the publication process.

Be accountable for all aspects of your work. This includes investigating and resolving any questions about accuracy or research integrity

Treat communications between you and the journal editor as confidential until an editorial decision has been made.

Read about our research ethics for authorship. These state that you must:

Include anyone who has made a substantial and meaningful contribution to the submission (anyone else involved in the paper should be listed in the acknowledgements).

Exclude anyone who hasn’t contributed to the paper, or who has chosen not to be associated with the research.

If your article involves human participants, you must ensure you have considered whether or not you require ethical approval for your research, and include this information as part of your submission. Find out more about informed consent.

Research and publishing ethics

Our editors and employees work hard to ensure the content we publish is ethically sound. To help us achieve that goal, we closely follow the advice laid out in the guidelines and flowcharts on the COPE (Committee on Publication Ethics) website.

We have also developed our research and publishing ethics guidelines. If you haven’t already read these, we urge you to do so – they will help you avoid the most common publishing ethics issues.

A few key points:

Any manuscript you submit to this journal should be original. That means it should not have been published before in its current, or similar, form. Exceptions to this rule are outlined in our pre-print and conference paper policies.  If any substantial element of your paper has been previously published, you need to declare this to the journal editor upon submission. Please note, the journal editor may use Crossref Similarity Check to check on the originality of submissions received. This service compares submissions against a database of 49 million works from 800 scholarly publishers.

Your work should not have been submitted elsewhere and should not be under consideration by any other publication.

If you have a conflict of interest, you must declare it upon submission; this allows the editor to decide how they would like to proceed. Read about conflict of interest in our research and publishing ethics guidelines.

By submitting your work to Emerald, you are guaranteeing that the work is not in infringement of any existing copyright.

Third party copyright permissions

Prior to article submission, you need to ensure you’ve applied for, and received, written permission to use any material in your manuscript that has been created by a third party. Please note, we are unable to publish any article that still has permissions pending. The rights we require are:

Non-exclusive rights to reproduce the material in the article or book chapter.

Print and electronic rights.

Worldwide English-language rights.

To use the material for the life of the work. That means there should be no time restrictions on its re-use e.g. a one-year licence.

We are a member of the International Association of Scientific, Technical, and Medical Publishers (STM) and participate in the STM permissions guidelines, a reciprocal free exchange of material with other STM publishers.  In some cases, this may mean that you don’t need permission to re-use content. If so, please highlight this at the submission stage.

Please take a few moments to read our guide to publishing permissions to ensure you have met all the requirements, so that we can process your submission without delay.

……

更多详情:

https://www.emeraldgrouppublishing.com/journal/nbri#author-guidelines

期刊编辑邮箱【官网信息】

Editor

Professor Jean Jinghan Chen

University of Macau - Macao

jeanchen@um.edu.mo

Professor Xinsheng Cheng

Nankai University - People's Republic of China

xinsheng86@126.com

Professor Dahui Li

University of Minnesota Duluth - USA

dli@d.umn.edu

Professor Yongjian Li

Nankai University - People's Republic of China

liyongjian@nankai.edu.cn

Professor Lihui Tian

Nankai University - People's Republic of China

LTian@nankai.edu.cn

Editor Assistant

Dr Fangchao Xu

Nankai University - People's Republic of China

xufc@nankai.edu.cn

Associate Editor

Deqiu Chen

University of International Business and Economics - People's Republic of China

nkchendq2006@163.com

Yong Chen

Texas A&M International University - USA

ychen@mays.tamu.edu

Chunxing Fan

Tennessee State University - USA

cfan@tnstate.edu

Kannan Govindan

University of Southern Denmark - Denmark

kgov@iti.sdu.dk

Jing Jiang

Sacred Heart University - USA

jiangj@sacredheart.edu

Dan Ke

Wuhan University - People's Republic of China

dkeuconn@gmail.com

Guiquan Li

Rennes School of Business - France

guiquan.li@rennes-sb.com

Yuzhu (Julia) Li

University of Massachusetts Dartmouth - USA

yuzhu.li@umassd.edu

Shuguang Liu

State University of New York at New Paltz - USA

liush@newpaltz.edu

Chen Lu

University of Electronic Science and Technology - People's Republic of China

gracechenlu@126.com

Shuang (Sara) Ma

Beijing International Studies University - People's Republic of China

sm@bisu.edu.cn

Ernesto Santibanez Gonzalez

Universidad de Talca, Chile

santibanez.ernesto@gmail.com

Ramaprasad Unni

Tennessee State University - USA

runni@tnstate.edu

Gang Wang

University of Delaware - USA

gangw@udel.edu

Na Wang

Huaqiao University - People's Republic of China

wangna@hqu.edu.cn

Shuai Yang

Donghua University - People's Republic of China

shuai.yang@dhu.edu.cn

Wenqing Zhang

University of Minnesota Duluth - USA

wqzhang@d.umn.edu

Haichao Zheng

Southwestern University of Finance and Economics - People's Republic of China

haichao@swufe.edu.cn

Hua Zhong

State University of New York at Oneonta - USA

zhongh@oneonta.edu

Publisher

Chloe Campbell

Emerald Publishing - UK

ccampbell@emerald.com

Journal Editorial Office (For queries related to pre-acceptance)

Shalaka Dattatraya Surve

Emerald Publishing

shalaka.emerald@kwglobal.com

Supplier Project Manager (For queries related to post-acceptance)

Sumit Maity

Emerald Publishing

sumit.emerald@kwglobal.com

中国全科医学发文选摘

  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析
  • 1、2019.V1版《NCCN结直肠癌诊治指南》更新要点解析

常见问题

  • 哪些期刊可以用来评职称?

    1、期刊要具备正规性和合法性,需在国家新闻出版总署备案,具备国内刊号(cn)。2、期刊要具备学术性,例如该期刊需被国内主流学术、数据库收录,例如被知网,万方,维普收录。具体详情可以咨询我们的客服老师为您解答。

  • 你们的服务可以保证文章被发表吗?

    期刊发表的成功与否,主要取决于文章内容的质量。期刊编辑会根据研究领域、创新性等多因素进行考量。我们会帮助您理解期刊的发表要求,助力提升发表几率,从而增加发表的机会。

  • 请问发表一篇期刊的费用是多少?

    期刊的种类繁多,其费用也各不相同。根据您的需求,将为您推荐最具性价比的期刊,让您能更便捷地找到心仪的期刊。一般来说,只要符合职称评定要求的,大多数作者都会选择性价比最高的期刊作为首选目标。

  • 如果发表不成功可以退款吗?

    如果因为我方原因导致未能发表成功,我们将全额退还相关费用。需要明确的是,稿件能否发表主要取决于期刊的独立考量。为了提升您的发表几率,我们会提供专业的指导和支持,帮助您避免拒稿,并助力提高您的稿件质量。

  • 请问文章发表需要多长时间?

    不同级别的期刊发表时间是不一样的。无论是普刊还是核心期刊,建议您提前准备。普刊需提前3-6个月,而核心期刊需提前一年左右。为确保职称评定流程顺利进行,建议您提前半年到一年进行准备,以免错过申请的最佳时机。

  • 期刊发表能加急见刊吗?

    为了确保顺利发表,建议您提前一些时间进行安排。本站仅提供投稿发表咨询服务,需要用户自己向出版商投稿且没有绿色通道,是否录用一切以出版商通知为准。